Brief Report: Preliminary Evidence of the N170 as a Biomarker of Response to Treatment in Autism Spectrum Disorder
Kala S, Rolison MJ, Trevisan DA, Naples AJ, Pelphrey K, Ventola P, McPartland JC. Brief Report: Preliminary Evidence of the N170 as a Biomarker of Response to Treatment in Autism Spectrum Disorder. Frontiers In Psychiatry 2021, 12: 709382. PMID: 34267691, PMCID: PMC8275957, DOI: 10.3389/fpsyt.2021.709382.Peer-Reviewed Original ResearchAutism spectrum disorderN170 latencyBehavioral treatmentSpectrum disorderFace-sensitive event-related potentialsComputer-generated facesEvent-related potentialsWaitlist control conditionASD displayFearful affectNeural processingN170Waitlist controlSubset of participantsPRT interventionElectroencephalography (EEG) dataNeurodevelopmental disordersAged childrenPreliminary evidenceObjective indexSocial functionLarge sampleExploratory studyParticipantsTreatment response